Global Retirement Partners’s ImmunityBio IBRX Stock Holding History

Global Retirement Partners’s Portfolio IBRX Stock Details IBRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$89.8K	Buy	+10,262	New	+$77.7K	﹤0.01%	2136
2025 Q4	$8.06K	Hold	4,072	–	–	﹤0.01%	3243
2025 Q3	$10K	Buy	4,072 +1,000	+33%	+$2.58K	﹤0.01%	2697
2025 Q2	$8.11K	Buy	+3,072	New	+$8.26K	﹤0.01%	2704
2024 Q4	$2.38K	Hold	930	–	–	﹤0.01%	3007
2024 Q3	$3.46K	Hold	930	–	–	﹤0.01%	2727
2024 Q2	$5.88K	Hold	930	–	–	﹤0.01%	2544
2024 Q1	$4.99K	Hold	930	–	–	﹤0.01%	2395
2023 Q4	$3.51K	Hold	930	–	–	﹤0.01%	2466
2023 Q3	$1.29K	Hold	930	–	–	﹤0.01%	2694
2023 Q2	$2.58K	Hold	930	–	–	﹤0.01%	2439
2023 Q1	$3.12K	Buy	+930	New	+$2.89K	﹤0.01%	2344

Other funds holding IBRX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Global Retirement Partners's IBRX Position: Q2 2026 in Review

Global Retirement Partners opened a new position in ImmunityBio (IBRX) in Q2 2026: 10,262 shares worth $89.8K. The stake represents ﹤0.01% of the portfolio and ranks #2136 among its holdings. This is a return to the name: Global Retirement Partners previously reported a position in IBRX as recently as Q4 2025.

Global Retirement Partners first reported a position in IBRX in Q1 2023 and has held it in 12 quarters since. 405 funds tracked by Wall St. Rank hold IBRX as of Q2 2026.

Global Retirement Partners held 10,262 shares of ImmunityBio worth $89.8K as of Q2 2026.
ImmunityBio was a new Global Retirement Partners position in Q2 2026.
ImmunityBio made up ﹤0.01% of Global Retirement Partners's portfolio in Q2 2026, its #2136 holding.
Global Retirement Partners first reported a position in ImmunityBio in Q1 2023 and has held it in 12 quarters since.
405 funds tracked by Wall St. Rank held ImmunityBio as of Q2 2026.

Based on Global Retirement Partners's 13F filing for Q2 2026, filed 6 Aug 2026.